COMPOSITION: | Each 5 ml of suspension contains Levocloperastine Fendizoate 20 mg |
FORMULATION: | LIQUIDS |
STATUS: | PRESCRIPTION ONLY DRUG |
DESCRIPTION: | Kofpetus syrup contains Levocloperastine a new anti-tussive drug. Kofpetus is effective in the treatment of cough associated with many chronic and acute conditions e.g. Bronchitis, Emphysema, Bronchial asthma and COPD in patients of all ages. |
SIDE EFFECTS: | Common side effects are Headache, palpitations, faintness, nausea, drowsiness and dizziness |
DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |